BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28830450)

  • 1. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
    Yang Y; Ding L; Hu Q; Xia J; Sun J; Wang X; Xiong H; Gurbani D; Li L; Liu Y; Liu A
    Mol Cancer; 2017 Aug; 16(1):141. PubMed ID: 28830450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.
    Zhang J; Jia J; Zhao L; Li X; Xie Q; Chen X; Wang J; Lu F
    Mol Carcinog; 2016 May; 55(5):732-42. PubMed ID: 25809226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.
    Ma H; Liu B; Wang S; Liu J
    Cell Biochem Funct; 2016 Dec; 34(8):613-619. PubMed ID: 27862077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5.
    Hu H; Zhang Q; Chen W; Wu T; Liu S; Li X; Luo B; Zhang T; Yan G; Lu H; Lu Z
    Carcinogenesis; 2020 Jun; 41(4):502-514. PubMed ID: 31233116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
    Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
    Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
    PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
    Wang X; Chen Z
    Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-124 enhances response to radiotherapy in human epidermal growth factor receptor 2-positive breast cancer cells by targeting signal transducer and activator of transcription 3.
    Fu Y; Xiong J
    Croat Med J; 2016 Oct; 57(5):457-464. PubMed ID: 27815936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
    Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-506 functions as a tumor suppressor in glioma by targeting STAT3.
    Peng T; Zhou L; Zuo L; Luan Y
    Oncol Rep; 2016 Feb; 35(2):1057-64. PubMed ID: 26554866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
    Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.